PD-(L)1 Inhibition and Cardiac Damage: A Relevant Toxicity?

Dirk De Ruysscher; Anne-Marie Dingemans; Marc Vooijs; Stephane Heymans

doi:10.1016/j.jtho.2018.02.008

PD-(L)1 Inhibition and Cardiac Damage: A Relevant Toxicity?

Dirk De Ruysscher, Anne-Marie Dingemans, Marc Vooijs, Stephane Heymans

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	478-479
Number of pages	2
Journal	Journal of Thoracic Oncology
Volume	13
Issue number	4
DOIs	https://doi.org/10.1016/j.jtho.2018.02.008
Publication status	Published - 1 Apr 2018

Keywords

CELL LUNG-CANCER
RADIATION-THERAPY
RADIOTHERAPY
DISEASE
TRIALS

Access to Document

10.1016/j.jtho.2018.02.008

Cite this

De Ruysscher, D., Dingemans, A-M., Vooijs, M., & Heymans, S. (2018). PD-(L)1 Inhibition and Cardiac Damage: A Relevant Toxicity? Journal of Thoracic Oncology, 13(4), 478-479. https://doi.org/10.1016/j.jtho.2018.02.008

@article{ebf073bd843e479fb27b8797e0927d98,

title = "PD-(L)1 Inhibition and Cardiac Damage: A Relevant Toxicity?",

keywords = "CELL LUNG-CANCER, RADIATION-THERAPY, RADIOTHERAPY, DISEASE, TRIALS",

author = "{De Ruysscher}, Dirk and Anne-Marie Dingemans and Marc Vooijs and Stephane Heymans",

year = "2018",

month = apr,

day = "1",

doi = "10.1016/j.jtho.2018.02.008",

language = "English",

volume = "13",

pages = "478--479",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",